Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 628–629 | Cite as

ASO Author Reflections: Elimination of Breast Cancer Surgery in Complete Responders After Neoadjuvant Chemotherapy: Imaging Perspective

  • Gaiane M. RauchEmail author
ASO Author Reflections



Gaiane Rauch has no conflicts of interest to disclose.


  1. 1.
    Rauch GM, Adrada BE, Kuerer HM, et al. Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer. AJR Am J Roentgenol. 2017;208:290–99.CrossRefGoogle Scholar
  2. 2.
    Kuerer HM, Vrancken Peeters M, Rea DW, et al. Nonoperative management for invasive breast cancer after neoadjuvant systemic therapy: conceptual basis and fundamental international feasibility clinical trials. Ann Surg Oncol. 2017;24(10):2855–2862.CrossRefGoogle Scholar
  3. 3.
    Kuerer HM, Rauch GM, Krishnamurthy S, et al. A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy. Ann Surg. 2018;267(5):946–951.CrossRefGoogle Scholar
  4. 4.
    Heil J, Kummel S, Schaefgen B, et al. Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques. Br J Cancer. 2015;113:1565–70.CrossRefGoogle Scholar
  5. 5.
    Rauch GM, Kuerer HM, Adrada BE. Biopsy feasibility trial for breast cancer pathologic complete response detection after neoadjuvant chemotherapy: imaging assessment and correlation endpoints. Ann Surg Oncol. 2018;25(7):1953–1960.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of Diagnostic RadiologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations